ChemoMetec ASOCSE:CHEMM +0.38%99 Market Cap is kr6,449.4 Mil as of Jun. 29, 2026. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 867 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 79.24% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ChemoMetec AS's share price for the quarter that ended in Dec. 2025 was kr687.5. ChemoMetec AS's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 17.4 Mil. Therefore, ChemoMetec AS's market cap for the quarter that ended in Dec. 2025 was kr11,963.9 Mil.
ChemoMetec AS's quarterly market cap
increased
from Dec. 2024 (kr8,460.9 Mil) to Jun. 2025 (kr10,171.5 Mil) and
increased
from Jun. 2025 (kr10,171.5 Mil) to Dec. 2025 (kr11,963.9 Mil).
ChemoMetec AS's annual market cap
declined
from Jun. 2023 (kr8,109.3 Mil) to Jun. 2024 (kr5,300.6 Mil) but then
increased
from Jun. 2024 (kr5,300.6 Mil) to Jun. 2025 (kr10,171.5 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ChemoMetec AS's Enterprise Value for Today is kr6,179.9 Mil.
ChemoMetec AS (OCSE:CHEMM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ChemoMetec AS Market Cap Related Terms
ChemoMetec AS Market Cap Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: Market Cap Comparison
For the Medical Devices subindustry, ChemoMetec AS's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Market Cap vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Market Cap distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ChemoMetec AS's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a Market Cap of kr6,449.4 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ChemoMetec AS and its competitors. According to the industry distribution chart, ChemoMetec AS ranks #180 out of 867 companies in the Medical Devices & Instruments industry, placing it in the top 20.8%.
Is ChemoMetec AS's Market Cap too high?
ChemoMetec AS's current Market Cap is kr6,449.4 Mil. Based on the distribution chart, ChemoMetec AS ranks #180 out of 867 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #180 out of 867 companies for Market Cap. This places ChemoMetec AS in the top 21% of its industry — outperforming the majority of peers. The industry median Market Cap is 117.03. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 117.03, based on 867 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 117.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Market Cap is kr6,449.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr370.60 — trading 29.2% below its estimated fair value. The current Market Cap is kr6,449.4 Mil. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Market Cap is kr6,449.4 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr370.60 is trading 29.2% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
Market Cap: kr6,449.4 Mil
GF Value™: kr523.33 vs. price of kr370.60 (29.2% below fair value)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
